| European NGOs back Indian generic drugs | 19-NOV-09 |
|
| Renowned European NGOs, including Oxfam and Medecins Sans Frontieres, have thrown their weight behind the Indian generic drug industry, whose products have been seized by authorities in Europe alleging violation of patents. |
|
|
|
| MNCs working against Indian drug firms: Sharma to WIPO | 11-NOV-09 |
|
| India today complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign against country's pharmaceutical industry, which has broken their "cartel" in the generic drugs. |
|
|
|
| India to raise drug seizure issue with EU this week | 04-NOV-09 |
|
| Perturbed by repeated confiscation of Indian drugs by EU authorities en route Africa and Latin America ostensibly on patent issue, the government will raise the matter during the India-EU Summit on Friday. |
|
|
|
|
|
|
|
|
|
|
|
|
| Drug makers vie to supply antidote | 11-AUG-09 |
|
| Large and small Indian drug manufacturers are flocking the offices of various state governments to secure manufacturing licences to supply cheap versions of Tamiflu (oseltamivir), the drug to treat the fast spreading swine flu, anticipating huge demand for the drug in the coming weeks. |
|
|
|
| UNITAID to meet Indian drug manufacturers | 23-JUN-09 |
|
| World Health Organisation (WHO) partner UNITAID today said it has organised a two-day meeting with Indian drug manufacturers to brief the companies about the programmes and initiatives undertaken by the mission. |
|
|
|
|
|
|
| Indian drugmakers facing takeover threat: Govt panel | 04-MAY-09 |
|
| Warning of significant takeover threats for most Indian drugmakers by their large foreign peers, an inter-ministerial task force has suggested the Government act proactively to strengthen the pharma industry. |
|
|
|
| Pharma exports hit by 1 per cent: IDMA | 04-MAY-09 |
|
| In the midst of recession eating into various overseas trade, it is now the Indian pharma industry that has taken a hit of one per cent in its exports, according to recent estimates by Indian Drug Indian Drug Manufaturers' Association (IDMA). |
|
|
|
| Taro may cost Sun Rs 1,000 cr | 02-MAY-09 |
|
| Indian drug firm Sun Pharma may have to shell out up to Rs 1,000 crore for acquiring the Israel-based Taro Pharma-ceuticals. “If we are able to get all the shares of Taro pharma-ceuticals, including promo-ters’, then the total cost would be up to Rs 1,000 crore,” the firm said. |
|
|
|
| IDMA to set up clusters in Guj to tackle high drug prices | 24-APR-09 |
|
| In a novel way to skirt the issue of price-controlled bulk drugs, the Gujarat state board of the Indian Drug Manufacturers' Association (IDMA) has iniatiated to form clusters and beat the burden of high prices of drugs. The move comes as a breather for the small and medium enterprise (SME) sector, which have to bear the high cost of drugs on individual purchases. |
|
|
|
| Merck eyes Indian drug biggie, brands | 30-JAN-09 |
|
| Germany-based Merck KGaA, the world’s oldest multinational pharmaceutical company, is eyeing to acquire a prominent Indian pharmaceutical company and established drug brands. This is part of Merck’s plan to achieve the target of Rs 3,200-crore revenue from its Indian operations within the next four years. |
|
|
|
| Ranbaxy to exit Japanese JV with Nippon Chemiphar | 16-JAN-09 |
|
| Ranbaxy Laboratories plans to exit its Japanese joint venture — Nihon Pharmaceuticals Industry (NPI)— by selling 50 per cent stake after the Indian drug maker was acquired by Japanese drug major Daiichi Sankyo. Ranbaxy will sell the stake back to its Japanese partner Nippon Chemiphar. |
|
|
|
Content Guide
